Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Seres Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.013 Ladies and gentlemen, thank you for standing by. 00:00:02.013 -- 00:00:05.276 My name is Desiree and I will be your conference operator today. 00:00:05.276 -- 00:00:10.201 At this time, I would like to welcome everyone to the Series Therapeutics First Quarter 00:00:10.201 -- 00:00:15.145 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background 00:00:15.145 -- 00:00:20.210 noise. After the speaker's remarks, there will be a question and answer session. 00:00:20.210 -- 00:00:24.074 If you would like to ask a question during this time, simply press star followed by the 00:00:24.074 -- 00:00:28.518 number one on your telephone keypad. If you would like to withdraw your question, again, 00:00:28.518 -- 00:00:32.504 press the star one. I would now like to turn the conference over to Dr. 00:00:32.504 -- 00:00:36.772 Carlo Tanvi of Investor Relations. You may begin. 00:00:36.772 -- 00:00:41.560 Thank you and good morning. Our press release with the company's first quarter 2025 financial 00:00:41.560 -- 00:00:44.786 results and business updates became available at 7 a.m. 00:00:44.786 -- 00:00:48.954 Eastern time this morning and can be found on the investors and news section of the company's 00:00:48.954 -- 00:00:53.947 website. The company has also posted an updated corporate presentation to the website. 00:00:53.947 -- 00:00:57.951 I'd like to remind you that we'll be making forward-looking statements, including statements 00:00:57.951 -- 00:01:02.615 about the timing and results of our clinical studies and data readouts, future product 00:01:02.615 -- 00:01:07.499 candidates, clinical development plans and commercial opportunities, communications with, 00:01:07.499 -- 00:01:12.744 feedback from, or subm...